This course reviews an FDA-approved treatment for VKC and its role within current management strategies. Participants will review patient selection, as well as when and how to incorporate this option into clinical practice.

Speaker: Mila Ioussifova OD, FAAO

Date: Tuesday, December 15, 2026

Time: 5:30 PM - 6:00 PM Pacific Time

Location: Virtual

Moderator: Pending

Cost: Free!

COPE ID: Pending

Category: Pending

This event is undergoing COPE approval for 1 hour CE credit.

Thank you to Harrow Pharmaceuticals for providing an educational grant to support this event.